1. Home
  2. VNDA vs KOPN Comparison

VNDA vs KOPN Comparison

Compare VNDA & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • KOPN
  • Stock Information
  • Founded
  • VNDA 2002
  • KOPN 1984
  • Country
  • VNDA United States
  • KOPN United States
  • Employees
  • VNDA N/A
  • KOPN N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • VNDA Health Care
  • KOPN Technology
  • Exchange
  • VNDA Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • VNDA 282.8M
  • KOPN 282.1M
  • IPO Year
  • VNDA 2006
  • KOPN 1992
  • Fundamental
  • Price
  • VNDA $4.82
  • KOPN $1.33
  • Analyst Decision
  • VNDA Strong Buy
  • KOPN Strong Buy
  • Analyst Count
  • VNDA 2
  • KOPN 4
  • Target Price
  • VNDA $16.50
  • KOPN $2.63
  • AVG Volume (30 Days)
  • VNDA 634.2K
  • KOPN 2.2M
  • Earning Date
  • VNDA 05-07-2025
  • KOPN 05-13-2025
  • Dividend Yield
  • VNDA N/A
  • KOPN N/A
  • EPS Growth
  • VNDA N/A
  • KOPN N/A
  • EPS
  • VNDA N/A
  • KOPN N/A
  • Revenue
  • VNDA $198,772,000.00
  • KOPN $44,266,305.00
  • Revenue This Year
  • VNDA $14.36
  • KOPN $21.20
  • Revenue Next Year
  • VNDA $44.53
  • KOPN $13.55
  • P/E Ratio
  • VNDA N/A
  • KOPN N/A
  • Revenue Growth
  • VNDA 3.18
  • KOPN 0.60
  • 52 Week Low
  • VNDA $3.86
  • KOPN $0.56
  • 52 Week High
  • VNDA $6.75
  • KOPN $2.17
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 50.56
  • KOPN 44.43
  • Support Level
  • VNDA $4.84
  • KOPN $1.32
  • Resistance Level
  • VNDA $5.04
  • KOPN $1.48
  • Average True Range (ATR)
  • VNDA 0.22
  • KOPN 0.12
  • MACD
  • VNDA -0.02
  • KOPN 0.01
  • Stochastic Oscillator
  • VNDA 31.48
  • KOPN 43.33

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: